Yu-Waye Chu

Insider Reports History

Entity
Individual
Location
Fate Therapeutics, Inc., 3535 General Atomics Court Ste 200, San Diego, CA
Signature
/s/ Lloyd Rowland, as Attorney-in-Fact for Yu-Waye Chu
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Yu-Waye Chu:

Stock Role Class Num Shares Value Price $ Report Date Ownership
FATE THERAPEUTICS INC Chief Medical Officer Common Stock 141K $615K $4.37 Apr 18, 2023 Direct
CytomX Therapeutics, Inc. Chief Medical Officer Performance Stock Units (PSUs) 75K $104K $1.38 Jan 18, 2024 Direct
CytomX Therapeutics, Inc. Chief Medical Officer Common Stock 26.3K $36.2K $1.38 Jan 18, 2024 Direct
CytomX Therapeutics, Inc. Chief Medical Officer Stock Option (Right to Buy) 123K Jan 18, 2024 Direct

Insider Reports Filed by Yu-Waye Chu

Symbol Company Period Transactions Value $ Form Type Date Filed Role
CTMX CytomX Therapeutics, Inc. Jan 18, 2024 3 $0 4 Jan 19, 2024 Chief Medical Officer
CTMX CytomX Therapeutics, Inc. Jul 19, 2023 1 $0 4 Jul 20, 2023 Chief Medical Officer
CTMX CytomX Therapeutics, Inc. Jul 19, 2023 0 $0 3 Jul 20, 2023 Chief Medical Officer
FATE FATE THERAPEUTICS INC Apr 18, 2023 2 -$16.6K 4 Apr 19, 2023 Chief Medical Officer
FATE FATE THERAPEUTICS INC Feb 6, 2023 1 $0 4 Feb 7, 2023 Chief Medical Officer
FATE FATE THERAPEUTICS INC Jan 10, 2023 1 -$41K 4 Jan 11, 2023 Chief Medical Officer
FATE FATE THERAPEUTICS INC Apr 19, 2022 1 -$144K 4 Apr 21, 2022 Chief Medical Officer
FATE FATE THERAPEUTICS INC Jan 25, 2022 2 $0 4 Jan 27, 2022 Chief Medical Officer
FATE FATE THERAPEUTICS INC Jan 11, 2022 2 -$192K 4 Jan 13, 2022 Senior VP Clinical Development
FATE FATE THERAPEUTICS INC Dec 10, 2021 9 -$264K 4 Dec 13, 2021 Senior VP Clinical Development
FATE FATE THERAPEUTICS INC Nov 19, 2021 1 $0 4 Nov 22, 2021 Senior VP Clinical Development